Yes, for now, in the US where it has been approved, Johnson & Johnson’s Janssen vaccine would significantly speed up the inoculation process, especially when in tandem with the other COVID vaccines already in use in the market, considering the company is ready to roll out its first batch as early as March. Not to mention the clear logistical advantages of the single dose vaccine will help amp up the vaccination drive and the supply shortage issue. In a previous statement put out by Johnson & Johnson, they claimed, ‘Janssen Plans to Produce More Than 1 Billion Doses of a Potential Vaccine to Be Distributed Globally Through 2021’. In its statement, the company also said that it expected to supply the 100 million doses it has promised the US by the end of June.